Latest Content

Government funding cuts to mental health and addiction programs create chaos, prompting swift restoration amid widespread concern from advocacy groups. Read the statement from the AFSP here.

In this CME article, explore the groundbreaking role of muscarinic cholinergic receptors in schizophrenia treatment, highlighting innovative therapies like KarXT for improved patient outcomes.

Artificial intelligence revolutionizes sports, enhancing performance and officiating, while raising concerns about the human element of competition.

Explore the multifaceted role of time in psychotherapy, from patient dynamics to treatment duration, and its impact on healing and growth.

LPCN 1154 shows promise as a rapid, at-home treatment for postpartum depression, with favorable safety results in ongoing phase 3 trials.

Exploring the vital link between nutrition and mental health, this article highlights dietary strategies to enhance psychiatric well-being and cognitive function.

Inpatient psychiatry faces an epidemic of violence, highlighting systemic neglect and the urgent need for reform to protect health care workers.

Explore the evolving landscape of psychiatry as it reflects on past events, current challenges, and future predictions for mental health.

BioXcel Therapeutics submits an sNDA to the FDA for Igalmi to treat agitation in bipolar disorder and schizophrenia at home.

Eating disorders pose a significant risk to athletes' health, highlighting the urgent need for awareness, support, and compassionate change in sports culture.

Researchers discuss precision medicine's potential to enhance opioid use disorder treatment.

Reflecting on Martin Luther King Jr.'s legacy, the article explores his insights on mental health, social justice, and the need for unity today.

Review the misperceptions patients and clinicians may have about ADHD diagnosis and treatment.